ANDA 206805, held by Ingenus Pharms LLC. Clobetasol Propionate.
As of Nov 16, 2026, ANDA 206805 (Clobetasol Propionate), held by Ingenus Pharms LLC, was first approved by FDA on Jul 31, 2017, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 2017 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clobetasol Propionate0.05% · aerosol, foam;topical | Clobetasol Propionate | Discontinued |
| Sep 6, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jul 31, 2017 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters